Liver Cancer
Copyright ©The Author(s) 2005.
World J Gastroenterol. Oct 21, 2005; 11(39): 6110-6114
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6110
Table 1 Relationship between high expression of COX-2 and clinical pathological features of liver cancer (mean+SD)
Clinical pathologicalfeaturesnStain fractiontP
AFP (ng/mL)
<2046.48+1.460.74>0.05
≥20246.36+1.15
Cell category
Liver cell category276.79+1.60
Bile duct cell category16.26+1.25
Transference in liver
Yes36.43+1.421.08<0.05
No257.15+1.80
Pathological differentiation
High228.25+0.865.23<0.05
Middle and low66.11+102
Table 2 Cell apoptosis rate and cell cycle after SMMC7402 was treated in experimental group and control group (n = 9, mean+SD)
GroupsApoptosis rateCell cycle (%)
(%)G0/G1SG2/M
Control group0.2540.39+3.8649.61+4.2713.10+1.03
Ad-LacZ0.4240.17+4.0350.18+3.6612.57+2.85
Ad-ASHcox-233.366.52+5.4822.15+3.2610.33+1.12
Table 3 Cell apoptosis rate and cell cycle after SMMC7721 was treated in experimental group and control group (mean+SD)
GroupsApoptosis rateCell cycle (%)
(%)G0/G1SG2/M
Control group0.5640.39+3.8649.61+4.2713.10+1.03
Ad-LacZ0.4842.17+2.6350.26+2.8512.27+2.72
Ad-ASHcox-20.9139.92+4.1149.28+4.1312.64+1.25